Core Viewpoint - MediPharm Labs Corp. has received a recommendation from Glass Lewis to support its nominees for the Board of Directors in the upcoming shareholder meeting on June 16, 2025 [1][2] Group 1: Shareholder Voting - Glass Lewis is the second independent proxy advisory firm to recommend voting for the Company's nominees, following a similar recommendation from ISS [2] - MediPharm urges shareholders to vote using the GREEN proxy to support all nominees and resolutions, with votes due by 3:00 p.m. Eastern time on June 13, 2025 [3] - Shareholders are encouraged to contact their broker for their control number to ensure their vote is counted [4] Group 2: Company Overview - Founded in 2015, MediPharm Labs specializes in the development and manufacture of pharmaceutical-quality cannabis concentrates and products [5] - The company received a Pharmaceutical Drug Establishment License from Health Canada in 2021, making it the only North American company with a commercial-scale GMP License for cannabinoid extraction [6] - In 2023, MediPharm acquired VIVO Cannabis Inc., expanding its reach to medical patients in Canada, Australia, and Germany [7]

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that it has not completed the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025 (collectively, the “Interim Filings”) by the previously anticipated date of June 13, 2025.‎ As previously disclosed, the dela ...

LAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the following results for each item of business considered at Planet 13’s Annual General Meeting of Stockholders held on Tuesday, June 10, 2025. Election of Directors The following table sets out the percentage of shares voted in respect of the election of directors: Nominee% For% WithheldRobert Groesbeck7 ...

Core Viewpoint - MediPharm Labs Corp. is urging shareholders to support its current strategy and board nominees while rejecting the dissident group's proposals, emphasizing the success of its recent transformation and growth strategy [1][3][5]. Company Strategy and Performance - MediPharm has successfully transformed its operations over the past three years, focusing on strategic business lines, divesting non-core assets, and reducing operating costs, which has led to improved financial performance [3][4]. - The acquisition of VIVO Cannabis Inc. in April 2023 has accelerated international growth and created synergies, contributing to the company's positive trajectory [3][15]. - In Q1 2025, MediPharm reported an 87% revenue increase in the international medical market, achieving positive Adjusted EBITDA for the first time in over five years, with a gross profit margin of 38.7% [4][5]. Shareholder Engagement - The company is encouraging shareholders to vote using the GREEN proxy to support its board nominees and resolutions, emphasizing the importance of each vote [2][11]. - MediPharm has provided resources for shareholders to ensure their votes are counted and to disregard communications from the dissident group [12][18]. Dissident Group's Position - The dissident group, led by Apollo Technology Capital Corp. and former MediPharm CEO Patrick McCutcheon, has proposed alternative directors but has been criticized for lacking a substantive plan and for misrepresentations in their communications [6][7]. - Independent advisory firm ISS has concluded that the dissident group did not present a compelling case for change, reinforcing the company's position [7]. Historical Context - The company highlights the negative performance metrics during McCutcheon's tenure, including a 72% revenue decrease in 2020 and significant operating losses, contrasting this with the current leadership's improvements since 2022 [9][16].

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the “Court”) has fully dismissed the application (CV-25-00743454-00CL) (the “Application”) issued by Apollo Technology Capital Corporation (“Apollo”) and Nobul Technologies Inc. (together with Apollo, the “Applicants”) against t ...

Core Viewpoint - Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has presented a plan aimed at revitalizing the company and enhancing shareholder value [1][6]. Shareholder Engagement - Shareholders are encouraged to vote for Apollo Capital's six director nominees using the "Gold Card" and to disregard MediPharm's "Green Card" [2][3]. - The communication emphasizes the urgency for shareholders to act in order to protect their investments [2][3]. Ownership and Influence - Apollo Capital, through its subsidiary Nobul Technologies Inc., owns approximately 3% of MediPharm's common shares, totaling 12,491,500 shares [4][6]. - The company is actively seeking to influence the board of directors through its proxy solicitation efforts [11]. Action Plan - Apollo Capital has outlined a commitment to execute an aggressive action plan aimed at increasing MediPharm's share price by over 10 times and preventing insolvency [6]. - The plan includes measures to address excessive executive compensation and rectify three years of value-destructive actions [6]. Legal and Regulatory Compliance - Apollo Capital has filed an amended dissident information circular in compliance with Canadian corporate and securities laws, detailing their director nominees and the rationale behind their actions [5][7]. - Shareholders are advised to read the amended circular carefully as it contains crucial information regarding the upcoming annual meeting [8].

Core Insights - HYTN Innovations Inc. has received its first purchase order and import permit for GMP cannabis vape cartridges, marking a significant milestone for the company [1][2] - The initial order consists of 1,000 one-gram live resin vape cartridges, which will be manufactured in compliance with GMP standards and exported to the UK, pending regulatory approvals [2] - The company emphasizes its commitment to quality and safety in its pharmaceutical-grade cannabis offerings, aiming to serve regulated international markets [2][3] Company Overview - HYTN Innovations Inc. specializes in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids [4] - The company aims to become a premier provider of these products across federally regulated markets by identifying market opportunities and innovating product development [4] GMP Compliance - Good Manufacturing Practices (GMP) guidelines ensure that manufactured products are safe for human consumption, and many countries require adherence to these standards [5] - The company's compliance with GMP standards is crucial for its operations and international market access [2][3]

Core Points - Herbal Dispatch Inc. has adjourned its 2024 and 2025 Annual General and Special Shareholder Meeting originally scheduled for June 10, 2025, to June 17, 2025 [1] - The adjourned meeting will be held virtually via Zoom and physically at a specified location in Vancouver, B.C. [1] - The company was unable to meet its proxy requirements for the former meeting, necessitating the adjournment [2] - All proxies submitted for the former meeting will remain valid for the adjourned meeting unless revoked or amended [3] Company Overview - Herbal Dispatch Inc. operates leading cannabis e-commerce platforms and aims to provide high-quality cannabis products at affordable prices [6] - The company's flagship marketplace, herbaldispatch.com, offers exclusive access to small-batch craft cannabis flower and various other product formats [6] - Herbal Dispatch's common shares are traded on the Canadian Securities Exchange under the symbol "HERB" [6]

Core Viewpoint - Tilray Brands, Inc. announced the approval of a reverse stock split at a ratio of 1-to-10 to 1-to-20, but has paused its implementation to evaluate timing and stock price [1][2]. Financial Structure - In the fiscal quarter ended February 28, 2025, Tilray reduced its total debt by approximately $76 million, resulting in a net debt to trailing twelve-months Adjusted EBITDA of less than 1.0x [3]. - As of the last fiscal quarter, Tilray's cash and marketable securities balance was approximately $250 million, providing financial strength and flexibility for strategic opportunities and acquisitions [3]. Strategic Objectives of Reverse Stock Split - The reverse stock split aims to ensure compliance with Nasdaq listing requirements, align the number of shares with similar companies, attract institutional shareholders, and potentially save up to $1 million annually in costs associated with stockholder meetings [7].

Core Insights - GrowGeneration Corp. has entered into a distribution agreement with V1 Solutions to expand its market presence in the European Union and Costa Rica, targeting the growing demand for hydroponic and organic gardening products [1][2][4] Group 1: EU Expansion - The partnership with V1 Solutions will leverage their strategic relationships with commercial cultivators in Europe, allowing GrowGen to meet the increasing demand for advanced cultivation products as cannabis regulations evolve [2][4] - Target markets in the EU include Germany, Portugal, Malta, Luxembourg, the Netherlands, Czech Republic, Greece, and Macedonia, all of which are experiencing significant cannabis cultivation developments [7] Group 2: Central America Expansion - GrowGen has launched its proprietary brands in Costa Rica, which has issued over 50 licenses for hemp and cannabis production in the past year, positioning it as a key growth market in Central America [3][4] - The favorable growing conditions and developing export infrastructure in Costa Rica enhance its potential for cannabis cultivation [3] Group 3: Product Offerings - GrowGen will supply its proprietary brands, including Drip Hydro, Char Coir, Ion Lighting, Power Si, and The Harvest Company, to commercial cultivators, garden centers, and licensed operators in the targeted regions [2][4] Group 4: International Strategy - The company is exploring additional markets in Eastern Europe and Latin America, aiming to serve high-growth regions through local partnerships and product education [4] - GrowGeneration's international sales infrastructure and regulatory expertise position it well to capitalize on the cannabis cultivation boom in regions with advancing legalization [4]